Abstract
Angiopoietin-like protein 7 (Angptl7) has been extensively studied for decades, but its potential immune functions have not been characterized. Hence, we investigated the relationship between Angptl7 and inflammation by using RAW264.7 monocyte/macrophage cells. The expression of genes encoding inflammation-associated factors cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), IL-6, IL-10, and transforming growth factor beta 1 (TGF-β1)) decreased after RAW264.7 cells were treated with anti-Angptl7 polyclonal antibody but increased after the cells were transfected with an Angptl7-expressing plasmid. Angptl7 overexpression enhanced phagocytosis and inhibited the proliferation of RAW264.7 cells. In addition, Angptl7 antagonized the anti-inflammatory effects of TGF-β1 and dexamethasone. Pathway analysis showed that Angptl7 promoted the phosphorylation of both p65 and p38, but only the P38 mitogen-activated protein kinase (MAPK) signaling pathway mediated Angptl7-associated inflammatory functions. Additionally, after 1 week of daily intraperitoneal injections of recombinant TNF-α in a mouse model of peripheral inflammation, Angptl7 expression increased in the mouse eyes. Thus, Angptl7 is a factor that promotes pro-inflammatory responses in macrophages through the P38 MAPK signaling pathway and represents a potential therapeutic target for treatment of inflammatory diseases.
Similar content being viewed by others
References
Kadomatsu, T., M. Tabata, and Y. Oike. 2011. Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases. FEBS Journal 278(4): 559–64.
Hato, T., M. Tabata, and Y. Oike. 2008. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends in Cardiovascular Medicine 18(1): 6–14.
Santulli, G. 2014. Angiopoietin-like proteins: a comprehensive look. Frontiers in Endocrinol (Lausanne) 5: 4.
Peek, R., B.E. van Gelderen, M. Bruinenberg, and A. Kijlstra. 1998. Molecular cloning of a new angiopoietin-like factor from the human cornea. Investigative Ophthalmology & Visual Science 39(10): 1782–8.
Peek, R., R.A. Kammerer, S. Frank, I. Otte-Holler, and J.R. Westphal. 2002. The angiopoietin-like factor cornea-derived transcript 6 is a putative morphogen for human cornea. Journal of Biological Chemistry 277(1): 686–93.
Comes, N., L.K. Buie, and T. Borras. 2011. Evidence for a role of angiopoietin-like 7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma. Genes to Cells 16(2): 243–59.
Kuchtey, J., M.E. Kallberg, K.N. Gelatt, T. Rinkoski, A.M. Komaromy, and R.W. Kuchtey. 2008. Angiopoietin-like 7 secretion is induced by glaucoma stimuli and its concentration is elevated in glaucomatous aqueous humor. Investigative Ophthalmology & Visual Science 49(8): 3438–48.
Parri, M., L. Pietrovito, A. Grandi, S. Campagnoli, E. De Camilli, F. Bianchini, et al. 2014. Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer. Angiogenesis.
Lim, S.Y., A. Gordon-Weeks, D. Allen, V. Kersemans, J. Beech, S. Smart, et al. 2015. CD11b myeloid cells support hepatic metastasis through downregulation of angiopoietin-like 7 in cancer cells. Hepatology.
Toyono, T., T. Usui, S. Yokoo, Y. Taketani, S. Nakagawa, M. Kuroda, et al. 2015. Angiopoietin-like 7 is an anti-angiogenic protein required to prevent vascularization of the cornea. PLoS One 10(1): e0116838.
Xiao, Y., Z. Jiang, Y. Li, W. Ye, B. Jia, M. Zhang, et al. 2015. ANGPTL7 regulates the expansion and repopulation of human hematopoietic stem and progenitor cells. Haematologica.
Hansson, G.K. 2005. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine 352(16): 1685–95.
Dandona, P., A. Aljada, and A. Bandyopadhyay. 2004. Inflammation: the link between insulin resistance, obesity and diabetes. Trends in Immunology 25(1): 4–7.
Bergman, M., M. Djaldetti, H. Salman, and H. Bessler. 2011. Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells? Inflammation 34(1): 22–8.
Murray, P.J., and T.A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology 11(11): 723–37.
Toso, C., J.A. Emamaullee, S. Merani, and A.M. Shapiro. 2008. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes. Diabetologia 51(11): 1937–46.
Tang, S., X.Y. Shen, H.Q. Huang, S.W. Xu, Y. Yu, C.H. Zhou, et al. 2011. Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264.7 macrophages through inhibition of the NF-kappaB and MAPK signaling pathways. Inflammation 34(2): 111–8.
Ahn, C.B., W.K. Jung, S.J. Park, Y.T. Kim, W.S. Kim, and J.Y. Je. 2015. Gallic acid-g-chitosan modulates inflammatory responses in LPS-stimulated RAW264.7 cells via NF-kappaB, AP-1, and MAPK pathways. Inflammation.
Fengyang, L., F. Yunhe, L. Bo, L. Zhicheng, L. Depeng, L. Dejie, et al. 2012. Stevioside suppressed inflammatory cytokine secretion by downregulation of NF-kappaB and MAPK signaling pathways in LPS-stimulated RAW264.7 cells. Inflammation 35(5): 1669–75.
Hinds Jr., T.D., S. Ramakrishnan, H.A. Cash, L.A. Stechschulte, G. Heinrich, S.M. Najjar, et al. 2010. Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Molecular Endocrinology 24(9): 1715–27.
Kihara, Y., H. Mizuno, and J. Chun. 2015. Lysophospholipid receptors in drug discovery. Experimental Cell Research 333(2): 171–7.
Zhu, F., W. Yue, and Y. Wang. 2014. The nuclear factor kappa B (NF-kappaB) activation is required for phagocytosis of staphylococcus aureus by RAW 264.7 cells. Experimental Cell Research 327(2): 256–63.
Kim, N.H., Y. Son, S.O. Jeong, J. Moon Hur, H. Soo Bang, K.N. Lee, et al. 2010. Tetrahydroabietic acid, a reduced abietic acid, inhibits the production of inflammatory mediators in RAW264.7 macrophages activated with lipopolysaccharide. Journal of Clinical Biochemistry and Nutrition 46(2): 119–25.
Pariante, C.M., B.D. Pearce, T.L. Pisell, C.I. Sanchez, C. Po, C. Su, et al. 1999. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 140(9): 4359–66.
Lim, S., E. Bae, H.S. Kim, T.A. Kim, K. Byun, B. Kim, et al. 2012. TRAF6 mediates IL-1beta/LPS-induced suppression of TGF-beta signaling through its interaction with the type III TGF-beta receptor. PLoS One 7(3): e32705.
Clark, A.R. 2007. Anti-inflammatory functions of glucocorticoid-induced genes. Molecular and Cellular Endocrinology 275(1–2): 79–97.
Lewis-Tuffin, L.J., and J.A. Cidlowski. 2006. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Annals of the New York Academy of Sciences 1069: 1–9.
Sethu, S., P.N. Pushparaj, and A.J. Melendez. 2010. Phospholipase D1 mediates TNFalpha-induced inflammation in a murine model of TNFalpha-induced peritonitis. PLoS One 5(5): e10506.
Daftarian, P.M., A. Kumar, M. Kryworuchko, and F. Diaz-Mitoma. 1996. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. Journal of Immunology 157(1): 12–20.
Sullivan, D.E., M. Ferris, H. Nguyen, E. Abboud, and A.R. Brody. 2009. TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. Journal of Cellular and Molecular Medicine 13(8B): 1866–76.
Aderem, A., and D.M. Underhill. 1999. Mechanisms of phagocytosis in macrophages. Annual Review of Immunology 17: 593–623.
Platt, N., H. Suzuki, Y. Kurihara, T. Kodama, and S. Gordon. 1996. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proceedings of the National Academy of Sciences of the United States of America 93(22): 12456–60.
Zhou, F., Y. Pan, Z. Huang, Y. Jia, X. Zhao, Y. Chen, et al. 2013. Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36. Cell Stress & Chaperones 18(5): 643–52.
Smoak, K.A., and J.A. Cidlowski. 2004. Mechanisms of glucocorticoid receptor signaling during inflammation. Mechanisms of Ageing and Development 125(10–11): 697–706.
Flavell, R.A., S. Sanjabi, S.H. Wrzesinski, and P. Licona-Limon. 2010. The polarization of immune cells in the tumour environment by TGFbeta. Nature Reviews Immunology 10(8): 554–67.
Kastan, M.B., and J. Bartek. 2004. Cell-cycle checkpoints and cancer. Nature 432(7015): 316–23.
Gilmore, T.D. 2006. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25(51): 6680–4.
Cuadrado, A., and A.R. Nebreda. 2010. Mechanisms and functions of p38 MAPK signalling. Biochemical Journal 429(3): 403–17.
Mercau, M.E., F. Astort, E.F. Giordanino, C. Martinez Calejman, R. Sanchez, L. Caldareri, et al. 2014. Involvement of PI3K/Akt and p38 MAPK in the induction of COX-2 expression by bacterial lipopolysaccharide in murine adrenocortical cells. Molecular and Cellular Endocrinology 384(1–2): 43–51.
An, H., H. Xu, Y. Yu, M. Zhang, R. Qi, X. Yan, et al. 2002. Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways. Immunology Letters 81(3): 165–9.
Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology 23(11): 549–55.
Lewis, C.E., and J.W. Pollard. 2006. Distinct role of macrophages in different tumor microenvironments. Cancer Research 66(2): 605–12.
Lewis, C., and C. Murdoch. 2005. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. American Journal of Pathology 167(3): 627–35.
Iannitti, T., A. Graham, and S. Dolan. 2012. Increased central and peripheral inflammation and inflammatory hyperalgesia in Zucker rat model of leptin receptor deficiency and genetic obesity. Experimental Physiology 97(11): 1236–45.
Kosacka, J., M. Kern, N. Kloting, S. Paeschke, A. Rudich, Y. Haim, et al. 2015. Autophagy in adipose tissue of patients with obesity and type 2 diabetes. Molecular and Cellular Endocrinology 409: 21–32.
Acknowledgments
This work was supported by grants from the National Key Basic Research Program of China (2012CB124702), the 948 Program (2012-S13 and 2013-S15), the Specialized Research Fund for the Doctoral Program of Higher Education (20110146130002), the Program of National Natural Science Foundation of China (31172093), the National Science Foundation for Fostering Talents in Basic Research (J1103510), and the Fundamental Research Funds for the Central Universities (2013PY005).
Author information
Authors and Affiliations
Corresponding author
Additional information
Highlights
- Angptl7 overexpression induces a pro-inflammatory phenotype in RAW264.7 cells.
- Angptl7 overexpression inhibits TGF-β and glucocorticoid pathways in RAW264.7 cells.
- The P38 MAPK signaling pathway mediates Angptl7-associated inflammatory functions in RAW264.7 cells.
- Intraperitoneal injection of TNF-α induces Angptl7 expression in mouse eyes.
ELECTRONIC SUPPLEMENTARY MATERIAL
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 31 kb)
Rights and permissions
About this article
Cite this article
Qian, T., Wang, K., Cui, J. et al. Angiopoietin-Like Protein 7 Promotes an Inflammatory Phenotype in RAW264.7 Macrophages Through the P38 MAPK Signaling Pathway. Inflammation 39, 974–985 (2016). https://doi.org/10.1007/s10753-016-0324-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-016-0324-4